TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
OCS

Oculis Holding AG

Healthcare · Biotechnology

9.10$ +0.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow OCS
Line item 2020 2021 2022 2023 2024 2025
-1,211.4% -1,440.1% -2,749.3% -6,098.0% -6,924.1% –
23.0% 24.5% 32.8% 32.5% 59.2% –
33.0% 34.2% 88.2% 408.6% 1,425.9% –
308.9% 550.3% – – – –
-45.4% -82.4% 657.7% -1,471.2% 2,064.3% –
1.9% 2.9% 389.0% 5.4% 33.5% –
-1.9% -2.9% -389.0% -6,139.4% -2,559.3% –
– – – 0.0% 0.0% –
-9.9% -16.6% -17.4% -17.9% -39.9% –
489.3% 5,749.4% 187.9% 14,685.4% 7,876.1% –
-725.1% 4,304.7% -2,904.7% 2,099.8% -1,548.0% –
-1,213.3% -1,443.0% -3,138.4% -6,103.4% -6,957.6% –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?